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Synaptic excitationAfter 1 h of lithium-pilocarpine status epilepticus (SE), immunocytochemical labeling of NMDA receptor NR1
subunits reveals relocation of subunits from the interior to the cell surface of dentate gyrus granule cells
and CA3 pyramidal cells. Simultaneously, an increase in NMDA-miniature excitatory postsynaptic currents
(mEPSC) as well as an increase in NMDA receptor-mediated tonic currents is observed in hippocampal slices
after SE. Mean-variance analysis of NMDA-mEPSCs estimates that the number of functional postsynaptic
NMDA receptors per synapse increases 38% during SE, and antagonism by ifenprodil suggests that an increase
in the surface representation of NR2B-containing NMDA receptors is responsible for the augmentation of both
the phasic and tonic excitatory currents with SE. These results provide a potential mechanism for an enhance-
ment of glutamatergic excitation that maintains SE andmay contribute to excitotoxic injury during SE. Therapies
that directly antagonize NMDA receptors may be a useful therapeutic strategy during refractory SE.
© 2013 Elsevier Inc. All rights reserved.Introduction
Despite the emergence of several new anticonvulsants, status
epilepticus (SE) is a major health concern with signiﬁcant morbidity
and a high mortality (DeLorenzo et al., 1996). As seizures persist, SE
becomes self-sustaining and increasingly difﬁcult to treat (Alldredge
et al., 2001; Mazarati et al., 1998a; Silbergleit et al., 2012; Treiman
et al., 1998), even after removal of the initial convulsant trigger
(Mazarati et al., 1998b; Morrisett et al., 1987; Suchomelova et al.,
2006). Previously we found that trafﬁcking of GABAA receptors, with
relocation of subunits from synapses to the cell interior, contributes
to a loss of postsynaptic inhibition in hippocampal dentate gyrus gran-
ule cells and may explain the initiation of self-sustaining SE and the
development of benzodiazepine pharmacoresistance (Naylor et al.,
2005).Whilemost GABAergic enhancing agents quickly lose effective-
ness during the course of SE (Goodkin and Kapur, 2003; Jones et al.,
2002; Kapur and Macdonald, 1997; Mazarati et al., 1998a; Rice and
DeLorenzo, 1998, 1999; Treiman et al., 1998), NMDA antagonistsearch Institute at Harbor-UCLA
ngeles Healthcare System and
n Street Bldg N-25 Neurology
irect.com).
rights reserved.
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x.doi.org/10.1016/j.nbd.2012retain effectiveness in the late stages of SE (Mazarati and Wasterlain,
1999; McDonald et al., 1990a; Mewasingh et al., 2003; Yen et al.,
2004) suggesting that NMDA receptors remain available for pharma-
cological intervention throughout SE.
Although NMDA receptor trafﬁcking is important in many pro-
cesses including development/experience (Quinlan et al., 1999a,
1999b; van Zundert et al., 2004), synaptic plasticity/LTP (Carroll and
Zukin, 2002; Grosshans et al., 2002; Watt et al., 2004), degenerative
disorders (Chen et al., 1999c; Lau and Zukin, 2007; Snyder et al.,
2005), and excitotoxicity/cell death (DeRidder et al., 2006; Gee et al.,
2006; Guerguerian et al., 2002; Johnston et al., 2002; Lekishvili et al.,
2006; Manzerra et al., 2001), the role of NMDA receptor trafﬁcking
in SE has not been investigated in detail. To explore the importance
of NMDA receptors in maintaining SE, we studied the trafﬁcking of
NMDA receptor subunits and found a relocation of NMDA receptor
subunits towards the cell surfacewith an associated increase in excita-
tion involving synaptic as well as tonic currents. This augmented exci-
tation, coupled with a loss of synaptic inhibition (Naylor et al., 2005),
provides an important mechanism for seizure maintenance during
SE and may contribute to SE-related excitotoxicity (Fujikawa, 1995;
Hardingham et al., 2002; Rice and DeLorenzo, 1998). It alsomay contrib-
ute to synaptic plasticity during the epileptogenic process (Delorenzo
et al., 2005; Mazarati et al., 2002a)— since progression to a chronic epi-
leptic state frequently follows SE (Lothman et al., 1990; Mazarati et al.,
1998b; Rice and DeLorenzo, 1998).of NMDA receptors increases glutamatergic excitation during status
.12.015
2 D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxMaterial and methods
Animal preparation
4–7 week old male Wistar rats (Simonsen Lab, Gilroy, California)
received lithium (3 mEq/kg intraperitoneal; night before) and
methylscopolamine (1 mg/kg subcutaneous) 30 min before either
pilocarpine (40 mg/kg intraperitoneal) or normal saline (Sigma,
St. Louis, Missouri). All animal studies were approved by the Institu-
tional Animal Care and Use Committee of the VA Greater Los Angeles
Healthcare System. After ~1 h from onset of stage 5 seizures (Racine,
1972), animals were anesthetized with pentobarbital (100 mg/kg)
and perfused-ﬁxed with 10% formaldehyde for immunocytochemis-
try or anesthetized with halothane for decapitation and hippocampal
slice preparation.
Induction of SE with neurokinin B (NKB) used a modiﬁcation of a
protocol described previously (Liu et al., 1999). Brieﬂy, rats were
implanted under isoﬂurane anesthesia (Abbott Labs, Chicago, Illinois)
with a bipolar stimulating electrode into the perforant path and a
bipolar recording electrode, combined with guide cannula, into the
granule cell layer of the dorsal dentate gyrus. All experiments were
performed in awake animals after at least 7 days recovery. Status
epilepticus was induced by injection through amicrosyringe (Hamilton
Co., Reno, Nevada) inserted into the guide cannula of 1 nmol NKB
(Sigma) dissolved in 1 μl DMSO, controls received 1 nmol NKB mixed
with 10 nmol of SR142801, a selective NK3 receptor antagonist, or
1 μl DMSO (solvent). EEG was recorded from dentate gyrus during
and for 24 h after injection.
Immunocytochemistry
Serial formaldehyde-ﬁxed 40 μm coronal sections were incu-
bated overnight in mouse anti-NR1, NMDA receptor subunit anti-
serum (5 μg/ml, Chemicon, Temecula, California) and rabbit anti-
synaptophysin antiserum (5 μg/ml, Zymed, San Francisco, California).
The sections then were incubated for 1 h in FITC-labeled goat anti-
rabbit IgG (1:200, Jackson, West Grove, Pennsylvania) and Cy3-labeled
donkey anti-mouse IgG (1:500,Jackson) diluted in PBS containing 1%
goat serum, horse serum and 0.3% Triton X-100. Confocal images were
acquired with a confocal cell-scanning microscope. For this study we
used a pinhole of 1.0 Airy units and objectives of 100× oil (NA 1.4),
resulting in an estimated optical section thickness (full width at half
maximum) of 0.62 μm. Excitation for the green and red signalswas pro-
vided by 488 nm and 568 nm laser lines. Controls with one label omit-
ted conﬁrmed that the bleed-through between channels with these
settings was minimal. Confocal stacks with optical section separation
(z-interval) of 0.488 μm were acquired through control and SE hippo-
campi. Optical sections were averaged three times to reduce noise.
Images were acquired at a digital size of 1024×1024 pixels. Images
generated in the two channels were merged using green/red pseudo-
coloring and were processed further using Adobe Photoshop 5.5
(Adobe Systems Inc., Mountain View, CA). Immunoreactive ‘puncta’
were deﬁned as discrete points along the neuron and dendrite with ﬂuo-
rescence intensity at least twice background. Colocalization was deter-
mined by examination by a blinded observer of yellowish ‘overlap’
images of synaptophysin andNR1 subunit immunoreactivity.We counted
all NR1 subunit-immunoreactive neuronal cell bodies and 20 CA3 proxi-
mal dendrites (25 μm length, more easily distinguished from background
in CA3 than DG) per section in 4 sections of dorsal hipporcampus per
animal. Data are given as means±SEM (n=3 per group). Statistical sig-
niﬁcance was determined using a Student's t-test for unpaired data.
EM post-embedding immunocytochemistry
NR1 localizationwas evaluated by post-embedding immuno-electron
microscopy. One hour after onset of lithium-pilocarpine SE or shamPlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012treatment, anesthetized animals (n=3 per group) were perfused with
4% phosphate-buffered paraformaldehyde and 0.1% glutaraldehyde. The
brains were then post-ﬁxed in the same ﬁxative for 3 h. Hippocampi
were dissected out, subsectioned into approximately 2–4 mm slices
and washed in 0.1 M phosphate-buffered saline (PB). Blocks were
dehydrated and embedded in London Resin White. Thin sections were
picked up on nickel grids, blocked with normal goat serum, cold ﬁsh
gelatin and nonfatmilk in PB buffer, and incubated for 24 h at room tem-
perature with mouse antibody against NR1 (MAB363; Millipore). Grids
were then washed in PB, incubated in anti-mouse immunoglobulin con-
jugated to 20 nm gold particles (1:120 in cold ﬁsh gelatin/PB), followed
by a wash in PB containing cold ﬁsh gelatin and 2.5 M NaCl, then by
several washes in water. Grids, stained with uranyl acetate and lead cit-
rate, were viewed using a Philips 201C electron microscope. The outer
25% of asymmetric synapses was deﬁned as ‘lateral’, an area where the
label might be perisynaptic rather than located inside the synaptic cleft
(Moga et al., 2006).
Electrophysiological recording: whole-cell patch clamp
After decapitation, rat brains were placed in ice-cold artiﬁcial
cerebrospinal ﬂuid (ACSF) containing (in mM): 126 NaCl, 2.5 KCl,
2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 D-glucose, 1 pyruvate, 0.3
ascorbic acid with pH=7.3 and no added Mg++. 350 μm coronal
sections (Leica VT1000S, Bannockburn, Illinois) were held in a cham-
ber at room temperature bubbled with 95% O2 and 5% CO2 until trans-
fer to a chamber perfused at 1.5 ml/min with 33–35 °C ACSF where
recordings from somata of visualized neurons were made using an
Axoclamp-2B ampliﬁer (Axon Instruments, Foster City, California). Slices
from some lithium control animals were incubated in 40 mg/l of pilocar-
pine for ~1 h to control for a direct pharmacological effect of pilocarpine.
Electrode solutions for NMDA-mEPSC recordings contained (mM): 140
Cs gluconate, 4 NaCl, 2 MgCl2, 10 Hepes, 0.05 EGTA, and 2 Mg-ATP
(Sigma). The holding potential was −60 mV. Electrode solutions were
titrated to pH 7.25 with osmolarity of 280–300 mOsm. Borosilicate
electrodes were pulled (Sutter, Novato, California) for a resistance
of 4–6 MΩ, and recordings with series resistance changes exceeding
50% were excluded.
Solutions and drugs
ACSF for NMDA-mEPSC recordings contained tetrodotoxin (1 μM;
Calbiochem, LaJolla, California), CNQX (10 μM), picrotoxin (30 μM),
D-serine (10 μM) (Sigma). ACSF included 3 mM kynurenic acid during
cutting and preparation of slices. Ifenprodil (3 μM) selectively antago-
nized NR2B subunit-containing NMDA receptors, and the non-selective
antagonist, APV (50 μM), added at the end of recordings conﬁrmed
their NMDA receptor origin (Sigma).
Data analysis
After 3 kHz low-pass ﬁltering with 20 kHz digitizing (Digidata
1200; Axon Instruments), event detection and analysis (e.g. peak
amplitude, rise-time, AUC) were with Synaptosoft (Decatur, Georgia),
Pclamp 9.2 (Axon Instruments) and software generously provided by
I. Mody (UCLA). All data are given as mean±standard deviation. A
Student's t-test was used to assess statistical signiﬁcance. The slow
gating-kinetics of NMDA receptors generates signiﬁcant variability
in NMDA-mEPSC time to peak and can account for the observed dif-
ferences between the attributes of mean mEPSC traces from a granule
cell (Fig. 4A) compared to those of individual mEPSC events (Fig. 4B—
cumulative probability distributions). Because events are aligned by
onset and not peak amplitude for mean traces, the amplitudes of
mean composites will be smaller than the average of the peaks from
each individual EPSC event.of NMDA receptors increases glutamatergic excitation during status
.12.015
3D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxComputer analysis
Mean and variance traces generated from superimposed NMDA-
mEPSCs recorded from a dentate gyrus granule cell were analyzed to
estimate the number of postsynaptic NMDA receptors (N), the open
single channel current (i), and the channel open probability (Popen).
The analysis used personal programs written for Matlab (MathWorks;
Natick, Massachusetts). NMDA-mEPSCs with absolute peak ampli-
tudes exceeding 60 pA were excluded. For channels with open proba-
bility Popen, the binomial distribution for the population of channels at
a synapse generating NMDA-mEPSCs has a mean current (I)
I ¼ N  Popen  i ð1Þ
and variance (σ2)
σ2 ¼ N  Popen  1−Popen
 
 i2 ð2Þ
Popen will depend on several factors, including the concentration of
glutamate in the synaptic cleft and the kinetics of the individual
NMDA receptors. Substituting Eq. (1) into Eq. (2) determines the par-
abolic equation,
σ2 ¼ i  I−I2=N ð3Þ
and eliminates Popen as a variable, allowing N and i determination
from optimized ﬁts of variance versus mean plots (Fig. 5A). Popen at
the peak of the mean trace can be determined subsequently by divid-
ing the peak amplitude of an NMDA-mEPSC by (N·i). Eqs. (1) through
(3) were adapted to allow some variability in the number of postsyn-
aptic receptors across the population of synapses that contribute to
the mEPSCs of a cell. For example, modiﬁcations of the equations
that allow two different sizes of synaptic activation (N1, N2) are
I ¼ F1  N1 þ 1−F1ð Þ  N2ð Þ  Popen  i ð1⁎Þ
σ2 ¼
h
F1  N1 þ 1−F1ð Þ  N2f g  Popen  1−Popen
 
þ F1  1−F1ð Þ  N2−N1ð Þ2  Popen2
i
 i2
ð2⁎Þ
where F1 is the fraction of events with N1 synaptic receptors.
Given the slow kinetics/rise-time of NMDA-mEPSC events with
great variability in onset of peak amplitude, the peak of the mean
trace is not equal to the mean of the peaks of the individual events.
Consequently, additional constraint on optimized ﬁts was provided
by simultaneous ﬁt of the distribution of the peak amplitudes of indi-
vidual NMDA-mEPSC (Fig. 5B) along with the ﬁt of modiﬁed Eq. (3)
to variance vs. mean plots (Fig. 5A). The assumption of a uniform
current (i) for synaptic receptors is not unreasonable as single con-
ductance states primarily characterize the synaptic, NR1-NR2A or
NR1-NR2B subunit-containing receptors (Brimecombe et al., 1997;
Clark et al., 1997; Erreger et al., 2005; Lieberman and Mody, 1999b).
Numerical methods
The error between model and data was minimized across succes-
sive trials using a simplex algorithm (Lagarias et al., 1998).
Results
SE is associated with relocation of NMDA NR1 receptor subunits from the
cell interior to synaptic or peri-synaptic areas
NR1 is the essential subunit of NMDA heteromeric receptors
(Monyer et al., 1992) and combines primarily with NR2A and/or
NR2B subunits in the hippocampus (Wenthold et al., 2003a, 2003b).
In granule and pyramidal cells from control hippocampi, NR1 subunit-
like immunoreactivity (LI) (red pseudocolor) localizes to the cell interior,Please cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012which is surrounded by the synaptophysin-LI (Fig. 1A, right upper panel,
green pseudocolor). After 1 h of SE, much of this NR1 subunit-LI
has relocated to discrete puncta which outline the cell membrane, and
frequently colocalizes with synaptophysin-LI, giving these overlaps a
yellow color (Fig. 1A, right lower panel). In hippocampal granule
cells (Fig. 1A), the number of overlaps between NR1 subunit-LI and
synaptophysin-LI increases from 1.85±0.18 per soma in controls to
7.15±0.28 in SE (pb0.001). In CA3 (Fig. 1B), the number of overlaps be-
tween synaptophysin-LI and NR1 subunit-LI increases from 3.30±0.33
on the somatic surface of controls to 7.60±0.44 with SE and from
2.50±0.64 for the 25 μm of proximal dendrite of controls to 9.30±
0.20 with SE (pb0.001). In CA1 somas, the number of overlaps increases
from 4.00±1.02 in controls to 8.40±0.34 in SE (p=0.002).
By electron microscopy immunocytochemistry, the number of
asymmetric synapses in the dentate granule cell layer which are
immunoreactive for NR1 increases from 8.4±2.8% in controls to
26.9±4.7% in SE (Fig. 2), conﬁrming the light microscopy results.
The percentage of asymmetric synapses with 1 gold particle increases
from 7.8±2.5% in controls to 22.2±3.8%, and that of synapses with
2–3 gold particles increases from 0.5±0.3% in controls to 4.7±1.2%
after SE (pb0.05; 1037 asymmetric control synapse, 724 asymmetric
SE synapses). A greater proportion of NR1 particles are located in the
periphery of asymmetric synapses after SE, suggesting the possibility
of a perisynaptic location and of lateral entry of subunits into synap-
ses (45.3±3.2% for controls versus 58.5±2.7% for SE; pb0.05).
Synaptic relocation of NR1 subunit-LI is also observed in another model
of SE induced by intrahippocampal injection of neurokinin B
Double labeling shows, in CA3 pyramidal neurons of control rats,
only 3±1 overlaps between synaptophysin- and NMDA NR1-LI on
the somatic surface, and 4±1.5 overlaps along the proximal 25-μm
of dendrites (Fig. 3A, upper panels). However, at the peak seizure ac-
tivity 30 min after administration of 1 nmol NKB, the overlaps signif-
icantly increase to 11.8±2.4 on the soma and 13.9±2.1 on proximal
dendrites respectively (Fig. 3A, lower panels), a 350–390% increase,
compared to only a 25±4% increase in number of overlaps in the
contralateral hippocampus, suggesting that this phenomenon is not
unique to the lithium-pilocarpine model (Fig. 3). By contrast, injec-
tion of 1 nmol NKB mixed with 10 nmol SR 142801 (an NKB receptor
antagonist; Sanoﬁ-Aventis, Bridgewater, New Jersey) did not signiﬁ-
cantly increase the number of overlaps between synaptophysin-LI
and NMDA NR1-LI on the surfaces of pyramidal neurons neurons
(3±1 overlaps on granule cell soma, 3.8±1 overlaps on the proximal
25-μm of dendrites), nor did it cause any seizures (data not shown).
An increase in NMDA-mEPSC amplitude suggests a gain of postsynaptic
NMDA receptors during SE
We used hippocampal slices obtained from animals in lithium-
pilocarpine SE for 1 h to examine whether the increase in synaptic
NR1 puncta reﬂects an increase in the number of functional postsyn-
aptic NMDA receptors. Mean traces of NMDA-mEPSCs recorded
from dentate gyrus granule cells in slices from SE animals (Fig. 4A) in-
crease peak amplitude to 123% of controls (−20.2±2.7 pA for SE vs
−16.4±0.64 pA for controls; pb0.001; n=16) and increase the
area-under-the-curve (AUC) to 132% of controls (−689±143 pA·ms
for SE vs −523±163 pA·ms for controls; pb0.01). Comparison with
additional controls with slices obtained from animals injected with
lithium the night before and then incubated in aCSF containing
40 mg/L of pilocarpine (n=9) for 1–2 h prior to recording showed
signiﬁcant increases in NMDA-mEPSC amplitude and AUC for SE
animals compared to these lithium-pilocarpine controls (pilocarpine
control peak amplitude −14.6±2.4 pA and AUC −464±216 pA·ms;
pb0.05). This suggests that the NMDA-mEPSC changes we observeof NMDA receptors increases glutamatergic excitation during status
.12.015
Fig. 1. Subcellular distribution of NMDA NR1 subunits with SE. Hippocampal sections through the dentate gyrus (A) and CA3 (B) of control (upper panels) and SE (lower panels)
stained with an antibody against NMDA NR1 subunits (red, left panels) and an antibody against the presynaptic marker synaptophysin (green, middle panels). Overlaps between
presynaptic synaptophysin and postsynaptic NR1 subunits appear yellow (right panels). Note increased NR1 subunit-LI colocalization with synaptophysin-LI for SE (right lower
panel) compared to controls (right upper panel), suggesting trafﬁcking of NMDA NR1 subunits towards the cell surface during SE. C, The number of colocalizations increase
with SE in principal cells of the dentate gyrus (DG), CA3 and CA1 compared to controls (error bars as±SEM).
4 D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxwith the lithium-pilocarpine model of SE are due to seizures and not a
lithium and/or pilocarpine pharmacological effect.
To interpret the basis for the increase in amplitude and AUC with
SE, mean-variance analysis of NMDA receptors (see Material andPlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012methods — Data analysis) provides estimates of the number of post-
synaptic receptors. The basic assumption of this analysis is that
NMDA-mEPSCs represent the sum of the individual postsynaptic recep-
tor current responses, and the individual receptors open and close in aof NMDA receptors increases glutamatergic excitation during status
.12.015
Fig. 2. Electron microscopy distribution of NR1-LI in asymmetric synapses of the granule cell layer of the dentate gyrus from control (A, upper panels) and SE animals (A, lower
panels). Arrows indicate the postsynaptic density (bars=150 nm). Examples of asymmetric synapses showing central/synaptic immunogold labeling (A, left panels) or a mix of
central/synaptic and lateral/perisynaptic immunogold labeling of postsynaptic densities (A, right panels) are shown. SE increases the percentage of immunogold-labeled asymmetric
synapses compared to controls (B, upper). The lateral distribution of NR1 on the surface of synapses increases with SE (B, lower). (Error bars as±SEM.)
5D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxprobabilistic manner with binomial statistics. Additional constraints
during optimized ﬁts of the mean-variance of NMDA-mEPSCs (Fig. 5A)
were provided by simultaneous ﬁt of the distribution of NMDA-mEPSC
peak amplitudes (Fig. 5B). This analysis suggests that the number ofPlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012NMDA receptors increases 38% from 8±1 per synapse in controls to
11±2per synapsewith SE (pb0.001; n=16). This relatively small num-
ber of NMDA receptors per control synapse is not unexpected (Bekkers
and Stevens, 1989; Kohr et al., 2003; Nimchinsky et al., 2004).of NMDA receptors increases glutamatergic excitation during status
.12.015
Fig. 3. Subcellular distribution of NMDA NR1 subunit-LI after NKB-induced SE. A, Hippocampal sections through CA3 of control (upper panels) and SE (lower panels) brains stained
with antibodies against the NR1 subunit-LI (red) and against the presynaptic marker synaptophysin-LI (green), with overlaps appearing yellow. Hippocampal sections of CA3 at
higher magniﬁcation are shown on the right. Note increased NR1 subunit-LI colocalization with synaptophysin-LI in pyramidal cells for NKB SE (bar — 40 μm left panel; 10 μm
right panel). B, The number of colocalizations increases with NKB SE at both the soma and proximal dendrites of CA3 pyramidal cells. (error bars as±SEM).
6 D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxSE causes alterations in synaptic NMDA-mEPSC kinetics
In addition to synaptic relocation of NMDA receptors, we ﬁnd
changes affecting NMDA-mEPSC kinetics. For mean traces of NMDA-
mEPSCs recorded from granule cells, an acceleration of the 10–90%
rise-time occurs (5.32±2.14 ms for SE vs 6.0±2.0 ms for controls;
pb0.001; n=14 each group). Also, a prolongation of the 63% decay-
time from 21.0±12.8 ms for controls to 24.4±8.3 ms with SE
(pb0.01) occurs, and the weighted-tau decay-time (AUC/peak ampli-
tude) also shows a prolongation (40.8±9.3 ms for SE vs 33.0±
12.8 ms for controls). For the individual NMDA-mEPSCs events from
granule cells, increases in peak amplitude (−27.3±5.25 pA for SE vs
−21.8±4.0 pA for controls; pb0.001) and AUC (−766±232 pA·ms
for SE vs −575±217 pA·ms for controls; pb0.001) with faster 10–
90% rise-times (6.7±2.7 for SE vs 8.4±3.9 ms for controls; pb0.01)
are observed. Cumulative probability distributions that pool individualPlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012NMDA-mEPSCs from multiple control or SE cells (Fig. 4B) show these
results graphically.
These changes may relate to SE-induced alterations of NMDA re-
ceptor kinetics and/or effects of SE on the spatiotemporal proﬁle of
glutamate release in the synaptic cleft. Results from mean-variance
ﬁts provide estimates for the single channel conductance comparable
to published values from single channel recordings (Clark et al., 1997;
Erreger et al., 2005) and suggest no change in channel conductance
with SE (64±2 pS for control vs 65±3 pS with SE; n.s.; n=14
each group), By this analysis, the estimate of channel open probability
at the peak of the mean NMDA-EPSC trace is 54±9% for controls
vs 45±3% after SE (pb0.001), possibly relating to changes in NMDA
receptor kinetics and/or subunit composition.
Other effects of SE include a decrease in mEPSC frequency from
0.96±0.63 Hz for controls to 0.73±0.52 Hz with SE (pb0.001).
Some decrease in the resting membrane potential from −68.3±of NMDA receptors increases glutamatergic excitation during status
.12.015
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Fig. 4. NMDA-mEPSCs from dentate gyrus granule cells of SE and controls. A, NMDA-mEPSC mean traces from a typical granule cell from a control (black) and a SE animal (gray),
demonstrating larger amplitude and area-under-the curve (AUC) in the latter (264 and 229 individual mEPSC events for themean control and SE cell traces, respectively). B, Cumulative
probability distributions for NMDA-mEPSCs fromcontrol (black) and SE (gray) granule cells. SE is associatedwith an increase in absolute peak amplitude andAUC, as indicated by a shift of
the curves towards larger absolute values. The 67% decay-time cumulative probability plot also shifts to longer valueswith SE. A small but signiﬁcant acceleration of the 10-90% rise-time is
notedwith SE aswell. The cumulative probability distributions include 4328 individual NMDA-mEPSC events (2859 events from 28 lithium-pilocarpine SE cells and 1469 events from 14
lithium-only control cells). Additional controls (14 cells) involving pilocarpine exposure in vitrowere not included. The number of events per cell was 102+/−59 for SE and 105+/−59
for controls (mean+/−s.d.).
7D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxx9.1 mV with controls to −65.2±8.6 mV with SE also is noted
(pb0.001). Both results may relate to injury and cell/synaptic loss
associated with SE.
NR2B subunit content of postsynaptic NMDA receptors increases with SE
In the presence of an antagonist of NR2B containing receptors
(ifenprodil; 3 μM; Sigma), mean SE NMDA-mEPSC traces (Fig. 6Aii)
decrease in amplitude from −17.38±4.71 pA to −15.16±2.04
(pb0.001; n=29) as the decay-time decreases from 24.4±8.3 to
19.3±9.1 (pb0.001) and AUC decreases from −739.5±243.5 to
−636.5±224.5 pA·ms (pb0.001) (Fig. 6Bii). For controls, mean
NMDA-mEPSCs (Fig. 6Ai) change from −15.56±1.70 to −15.01±
1.87 (n.s.; n=14) with ifenprodil as AUC changes from −553.2±
190.5 to −611.21±291.4 (n.s.), and no signiﬁcant changes arePlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012noted with decay-time either (Fig. 6Bi). After ifenprodil, no signiﬁcant
difference between SE and controls exists with respect to NMDA-
mEPSC amplitude (−15.2±2.04 vs 15.0±1.9), decay-time (19.3±
9.1 ms vs 23.8±21.2), AUC (−636.5±224.5 vs −611.2±291.4),
although a faster R-T with SE persists after ifenprodil (5.1±2.3 ms
with SE vs 5.99±2.0 ms with controls). This suggests that NR2B-
containing receptors account for most of the SE-related increases
in NMDA-mEPSC amplitude and AUC and also contribute to NMDA-
mEPSC kinetic changes such as a prolongation in decay-time. Mean-
variance analysis of NMDA-mEPSCs before and after ifenprodil (Fig. 7)
suggests 1.9±1.6 receptors per synapse are ifenprodil-sensitive in
slices from SE brains (pb0.001; paired t-test; n=17) vs 0.7±1.6 for
controls (n.s.; n=8). These computations further support the conclu-
sion that NR2B-containing receptors mediate the increase in NMDA-
mEPSCs with SE.of NMDA receptors increases glutamatergic excitation during status
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8 D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxIncreases in NMDA tonic currents during SE are mediated by
NR2B-containing receptors
With ifenprodil in the perfusate, a positive tonic current baseline
shift from of −76.0±41.1 pA to −66.8±34.5 pA (pb0.05; n=17)
for SE granule cells held at −60 mv reveals a depolarizing tonic cur-
rent of +9.2 pA mediated by NMDA receptors containing NR2B sub-
units (Fig. 8). No tonic current shift is observed with addition of
ifenprodil to controls (−2.6±12.9 pA; n.s.; n=5). After ifenprodil,
addition of APV (~50 μM) directly to the chamber produces a similar
positive tonic current baseline shift for either SE (+24.9±24.4 pA,
pb0.001) or control (+27.8±19.3 pA, pb0.02) granule cell record-
ings, with no signiﬁcant difference in the baseline shift between SE
and controls. For SE cells, the tonic NMDA current contribution from
NR2B-containing receptors is ~37% of the total. This suggests that sur-
face accumulation of NR2B-containing NMDA receptors is primarily
responsible for the increase in tonic NMDA currents with SE, similar
to our observations for phasic NMDA-mEPSC currents.
Discussion
After 1 h of SE, dentate granule cells display a 25% increase in
mEPSC amplitude, a 38% increase in the number of physiologically
active NMDA receptors per somatic synapse, a two-fold increase in
the number of NR1 subunit-LI in the vicinity of the presynaptic marker
synaptophysin, and a three-fold increase in NR1-like immunoreactivity
associated with postsynaptic densities. The NR1 immunoreactivity is
likely a marker for functional heteromeric NMDA receptor complexes
because all hippocampal NMDA receptors contain NR1 subunits, and
solitary NR1 subunits are retained in the ER (Prybylowski et al., 2002).Please cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012These changes could in part account for the enhanced glutamatergic
excitation that has been described in SE (Wasterlain et al., 2000), and
for the therapeutic efﬁcacy of NMDA antagonists in some models of SE
(Bertram and Lothman, 1990; Mazarati and Wasterlain, 1999). This
movement of NMDA receptor subunits towards the vicinity of synapses
coincides with a movement of the GABAA receptor β2/β3 and γ2 sub-
units from the cell surface to cytoplasmic sites (Goodkin et al., 2005;
Naylor et al., 2005). Hence, the direction of trafﬁcking during SE is re-
ceptor type-speciﬁc. The net movement of NMDA and AMPA (Naylor,
unpublished observations) receptors towards the cell surface and to-
wards synapses and themovement of GABAA receptors away from synap-
ses appear maladaptive in a seizing brain, and risk to further exacerbate
an imbalance between synaptic inhibition and synaptic excitation.
Normalization of synaptic physiology with slice incubation may
partially account for the lower estimate obtained from physiological
data compared to immunocyotchemistry. A similar difference between
anatomical and physiological measures is observed with GABAA recep-
tor trafﬁcking during SE (Naylor et al., 2005). Alternatively, immuno-
cytochemisty may detect extrasynaptic surface receptors that do not
contribute to NMDA-mEPSC responses. It has been shown that delivery
of functional NMDA receptors to the cell surface does not necessarily
increase the number of functional synaptic receptors (Prybylowski
et al., 2002). Many factors, including receptor trafﬁcking from existing
cytosolic pools, can regulate surface expression of NMDA receptors at
synaptic and extrasynaptic sites. Local de novo synthesis of subunits
seems unlikely given the profound inhibition of protein synthesis
and the compromised bioenergetic balance during SE (Fujikawa et al.,
1988; Wasterlain, 1974), although over-expression of NR1 and NR2B
subunits has been reported 24 h after pilocarpine in neuronal cultures
(Di Maio et al., 2011).of NMDA receptors increases glutamatergic excitation during status
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the decay-times and rise-times of NMDA-mEPSCs as well. The cumulative probability plots post-ifenprodil include 1044 NMDA-mEPSC events from 16 lithium-pilocarpine SE cells and
571 events from 8 lithium-only control cells. Additional controls (8 cells) involving pilocarpine exposure in vitro were not included.
9D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxThe increase of synaptic NMDA receptors may characterize an im-
portant transition when augmented synaptic excitation, coupled with
a major loss of synaptic inhibition (Naylor et al., 2005), provides thePlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012framework for progression from single seizures to self-sustaining
SE. While loss of inhibition may be important with initiation of SE, aug-
mented glutamatergic excitation is important for themaintenance of SEof NMDA receptors increases glutamatergic excitation during status
.12.015
Fig. 7. Mean-variance plots and NMDA-mEPSC peak amplitude distributions with model ﬁts for control (A) and SE (B) granule cells before (i) and after (ii) ifenprodil. Mean-variance
analysis of NMDA-mEPSCs with data (grey) and optimized model ﬁts (black). The corresponding histogram of NMDA-mEPSC peak amplitudes from that granule is cell shown below
each mean-variance plot along with the model-predicted distribution (bullet). Comparison of model results for A) control (n=6) and B) SE (n=10) granule cells before (i) and after
(ii) ifenprodil (3 μM) estimates a signiﬁcant increase of 1.9+/−1.6 ifenprodil sensitive NMDA receptors per synapse for SE, with no signiﬁcant increase noted in controls.
10 D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxx(Mazarati andWasterlain, 1999; Rice and DeLorenzo, 1999; Wasterlain
et al., 2000). This is consistent with the observation that GABAergic
drugs show a signiﬁcant, time-dependent loss in potency during
SE while NMDA antagonists are therapeutically effective even when
administered late in SE (Mazarati and Wasterlain, 1999; Yen et al.,
2004). Clinically, the NMDA antagonist ketaminewas anecdotally effec-
tive after 24–48 h of seizure activity in 5 patients (Mewasingh et al.,
2003). These ﬁndings have therapeutic implications: the standard ini-
tial treatment of SE (benzodiazepines) is insufﬁcient because increased
glutamatergic excitation is untouched. Furthermore, benzodiazepines
are unlikely to fully restore GABAergic inhibition given the dramatic
reduction of postsynaptic receptors available for allosteric activation.
Combinations of a benzodiazepine with an antagonist at NMDA
receptors and another drug which increases inhibition at a non-
benzodiazepine site would more fully address the effects of SE-
induced receptor trafﬁcking. Indeed, such combinations seem to be
more effective than monotherapy at stopping SE (Wasterlain et al.,
2011). Certain agents including felbamate (with dual agonist/antagonist
actions on GABAergic and glutamatergic receptors, respectively) may
have distinct therapeutic potential in SE (Rho et al., 1994).Please cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012While we have yet to evaluate the precise temporal and sequential
relation for loss of inhibition (Goodkin et al., 2005; Naylor et al.,
2005) and gain of excitation during SE, our results suggest that both
become signiﬁcant by 1 h of experimental seizure activity. In addition,
signiﬁcant interplay may exist between the gain of glutamatergic exci-
tation and loss of inhibition. An increase of NMDA receptor activity
during SE may contribute to a down-regulation of GABAergic inhibition
in some models of epilepsy (Kapur and Lothman, 1990), and NMDA
blockade can prevent the loss of effectiveness of GABA enhancing
drugs in a model of SE (Rice and DeLorenzo, 1999). We also ﬁnd that
non-NMDA glutamatergic synaptic receptors are upregulated during
SE (Naylor, unpublished observations), and the augmentation of NMDA
receptors we ﬁnd here may be crucial in that regard (Lu et al., 2001;
Shi et al., 1999).
Kinetic changes at excitatory synapses during SE include an accel-
eration of the NMDA-mEPSC rise-time along with a prolongation
of the tau weighted-decay and a decreased peak open probability.
Since subunit subtypes determine NMDA receptor properties, traf-
ﬁcking of postsynaptic NMDA receptors involving shifts in subunit
composition can alter receptor kinetics and NMDA-mEPSC attributes.of NMDA receptors increases glutamatergic excitation during status
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Fig. 8. Ifenpodil-sensitive component of NMDA tonic currents of granule cells after SE.
Recordings from typical granule cells from control and SE animals. Note an NR2B-
dependent component of the NMDA tonic current for SE cells but not controls, as
revealed by a signiﬁcant baseline shift with addition of the NR2B receptor antagonist
ifenprodil (3 μM) with no signiﬁcant baseline shift noted with ifenprodil in controls.
Both control and SE cells have signiﬁcant baseline shifts with the subsequent addition
of the non-selective NMDA receptor antagonist, APV.
11D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxxNR2B subunit-containing NMDA receptors have slower deactivation
kinetics (Flint et al., 1997; Prybylowski et al., 2002) and greater
charge transfer with a lower open probability compared to NR2A
subunit-containing receptors (Chen et al., 1999b; Erreger et al.,
2005) suggesting the kinetic properties we observe are consistent
with a greater proportion of NR2B subunit-containing receptors at
synapses. As both NR2A and NR2B subunits can exist at synaptic
and extrasynaptic sites (Berberich et al., 2005; Liu et al., 2004;
Massey et al., 2004), and a single synapse can contain both NR2A
and NR2B subunits as components of NMDA receptor complexes
(Kohr et al., 2003), slight shifts in subunit composition could account
for the decrease in Popen we observe with SE. Similarly, because recep-
tors containing NR2B subunits have a higher ligand binding afﬁnity
than those containing NR2A subunits (Erreger et al., 2005), kinetic
changes in NMDA-mEPSC rise-times and decay-times during SE also
could be explained by alterations in subunit composition at synapses.
Movement of receptors toward the center of synapses could affect
NMDA-mEPSC kinetic properties such as rise-time as well (Harney
et al., 2008), and although electron microscopy immunocytochemis-
try reveals a greater proportion of NMDA NR1 subunits at the periph-
ery of synapses, a dramatic increase of subunits is noted at all synaptic
locations including synapse centers. Alternatively, the increase in
mEPSC-NMDA rise-time associated with a decrease in event frequen-
cy partially may relate to selective vulnerability of distal (ﬁltered)
excitatory synapses during SE and slice preparation.
Selective pharmacological blockade of NR2B subunit-containing
receptors suggests that the increases in both phasic and tonic NMDA
receptor-mediated currents during SE is secondary to an increase in
NR2B-containing NMDA receptors, probably located at synaptic and
extrasynaptic sites, respectively, because similar to tonic GABAergic
currents, excitatory tonic currents from NMDA receptors may originate
from extrasynaptic receptors (Le Meur et al., 2007). While an increase
in synaptic spillover of glutamate to extrasynaptic receptors potentially
could contribute to the activation of an increased number of receptorsPlease cite this article as: Naylor, D.E., et al., Rapid surface accumulation
epilepticus, Neurobiol. Dis. (2013), http://dx.doi.org/10.1016/j.nbd.2012with SE NMDA-EPSCs, our immunocytochemistry ﬁndings show clear
increases in the synaptic location of NMDA receptor subunits and spill-
over should be minimal with miniature EPSC recordings. Furthermore,
the NR2B subunit speciﬁcity we observe for NMDA-mEPSC current
increases with SE would not be expected with spillover, which should
indiscriminately activate all available receptors including those con-
taining NR2A as well as NR2B subunits. In fact, no signiﬁcant phasic or
tonic current differences are noted between SE and control cells after
antagonism of NR2B-containing receptors. This result also suggests
that, unlike the SE-induced increase of a tonic GABAA current attributed
to a rise in extracellular [GABA] (Naylor et al., 2005), the increase of a
tonic glutamatergic NMDA current in granule cells relates to the de
novo appearance of NR2B subunit-containing receptors at extrasynaptic
sites. Our pharmacological ﬁndings for early SE are compatible with
immunohistochemical increases in postsynaptic NR2B subunits that
are reported to occur within 2 h for an electrically-induced model
of SE (especially for Tyr1472 phosphorylated NR2B that associates with
the synaptic scaffolding protein PSD-95), while increases in extra-
synaptic NR2B receptors are noted by 96 h after SE (Frasca et al.,
2011). Whether NR2B subunit-containing receptors ﬁrst accumulate
extrasynaptically on the neuronal membrane and then migrate to
synapses (Chen et al., 1999a; Prybylowski et al., 2002; Tovar and
Westbrook, 2002; Triller and Choquet, 2003) is not clear from our
analysis.
Other factors can contribute to the changes in receptor kinetics
and surface expression that we observe: variations in the dynamics or
concentration of transmitter release and uptake during SE, activity-
dependent changes in receptor kinetics/desensitization (Krupp et al.,
2002; Vissel et al., 2001), and changes in the phosphorylation state of
NMDA receptors (Carroll and Zukin, 2002; Friedman et al., 1997; Lan
et al., 2001; Li et al., 2001; Lieberman and Mody, 1999a; Lin et al.,
2006; Lu et al., 2000; Moussa et al., 2001) that also may affect NMDA
receptor expression at synapses (Frasca et al., 2011; Li et al., 2003; Lin
et al., 2004, 2006; Rycroft and Gibb, 2004; Wenthold et al., 2003a;
Yaka et al., 2002). For example, kinase activation during SE (Beldhuis
et al., 1992; Dunah et al., 2004; Huo et al., 2006; Kohira et al., 1992;
Niimura et al., 2005; Osonoe et al., 1994; Prybylowski et al., 2005)
can affect NMDA receptor channel properties (Ali and Salter, 2001;
Moussa et al., 2001) and both receptor interactions with the AP2-
clathrin endocytotic complex (Li et al., 2002; Vissel et al., 2001) and
delivery to synapses (Grosshans et al., 2002; Lan et al., 2001; Scott
et al., 2003). BDNF, also activated during SE (Kornblum et al., 1997),
affects NMDA receptor phosphorlyation (Wyneken et al., 2003) and
cell-surface stability.
The increased number of NMDA receptors at the cell surface
during SE has important implications for cell injury and cell death
as well as for the subsequent development of chronic epilepsy.
Over-activity of NMDA receptors can increase neuron death during
epileptic seizures, stroke, trauma or neurodegenerative disorders
(Choi, 1994a, 1994b; During et al., 2000; McDonald et al., 1990a,
1990b), and NMDA receptor blockade can provide neuroprotection
with SE, ischemia or excitotoxicity (Brandt et al., 2003; Clifford
et al., 1990; Frasca et al., 2011; Fujikawa, 1995; Rice and DeLorenzo,
1998; Seo et al., 2009; Starr and Starr, 1994). In addition, extra-
synaptic NMDA receptors that contain NR2B subunits have been
implicated with neurotoxicity, degeneration, and cell death (Fong et
al., 2002; Hardingham et al., 2002; Milnerwood et al., 2010). Blockade
of NMDA receptors reduces CA1 and CA3 cell death after pilocarpine-
induced SE (Frasca et al., 2011; Fujikawa, 1995) and mossy ﬁber
sprouting after KA-induced SE (Rice and DeLorenzo, 1998), while
also slowing kindling (McNamara et al., 1988) and preventing the
development of spontaneous recurrent seizures in some models of
epileptogenesis (Prasad et al., 2002; Rice and DeLorenzo, 1998). Of
note, felbamate and its close relative ﬂuorofelbamate have a prefer-
ence for antagonism of NR2B subunit-containing receptors (Harty
and Rogawski, 2000) and reduce SE-associated neuronoal injuryof NMDA receptors increases glutamatergic excitation during status
.12.015
12 D.E. Naylor et al. / Neurobiology of Disease xxx (2013) xxx–xxx(Mazarati et al., 2000) and SE-associated epileptogenesis (Mazarati
et al., 2002b). NMDA-Ca2+ dependent cell death in the hippocampus
may have a role in the development of chronic sequelae after SE
(Deshpande et al., 2008).
Conclusion
The increase in excitatory NMDA currents early during SE (primarily
from NMDA receptors containing NR2B subunits) and the trafﬁcking of
NMDA receptors from the cell interior to synaptic and extrasynaptic
sites may contribute to excessive levels of excitation during SE, and
may maintain seizure activity initiated by a loss of synaptic GABAA
receptors (Goodkin et al., 2008; Naylor et al., 2005). It may aggravate
seizure-induced benzodiazepine pharmacoresistance during SE by
adding an excitatory component unresponsive to standard treat-
ment with GABAA receptor agonists. The seizure-induced relocation
of NMDA receptors to the cell surface helps explain why late treat-
ment with NMDA antagonists is effective in some models of SE (Borris
et al., 2000; Mazarati and Wasterlain, 1999; Mewasingh et al., 2003),
long after benzodiazepine loss of potency (Kapur and Macdonald,
1997; Mazarati et al., 1998a; Treiman et al., 1998; Walton and Treiman,
1988), and offers a potential site for pharmacological intervention.
Agents that directly block glutamatergic receptors or shift the balance
of kinase and phosphatase activity to reduce NMDA receptor surface
expression deserve investigation in treating SE and in reducing its
long-term complications and may be most effective in combination
with GABAA agonists and other traditional anticonvulsants (Wasterlain
et al., 2011).
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